Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 90 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01AR073665,R01AR069502
Boehringer Ingelheim
Grant: Collaborative Research Agreement: Role
Boehringer Ingelheim
Grant: therapeutic blockade of IL-36 in atopic dermatitis
NIGMS NIH HHS
Grant: T32 GM136577
NIAMS NIH HHS
Grant: R01 AR069502
NIAMS NIH HHS
Grant: R01 AR074846
NIAMS NIH HHS
Grant: R01 AR073665
National Institutes of Health
Grant: 5R01AR069502-02
STAT3-mediated immunity to Staphylococcus aureus in skin
FWCI
11.21
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals